Pronzato P - Search Results

1

Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.

Pronzato P, Rubagotti A, Amoroso D, Bertelli G, Queirolo P, Sertoli MR, Rosso M, Gallotti P, Monzeglio C, Rosso R. Pronzato P, et al. Am J Clin Oncol. 1993 Dec;16(6):522-5. doi: 10.1097/00000421-199312000-00013. Am J Clin Oncol. 1993. PMID: 8256770 Clinical Trial.

2

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Campora E, et al. Among authors: pronzato p. Anticancer Res. 1992 Sep-Oct;12(5):1555-8. Anticancer Res. 1992. PMID: 1444221

3

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.

Repetto L, Miglietta L, Gardin G, Naso C, Giudici S, Merlini L, Queirolo P, Campora E, Pronzato P, Rosso R. Repetto L, et al. Among authors: pronzato p. Ann Oncol. 1992 Feb;3(2):165-6. doi: 10.1093/oxfordjournals.annonc.a058135. Ann Oncol. 1992. PMID: 1606088 Free article.

4

Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancer.

Pronzato P, Bertelli G, Amoroso D, Pennucci C, Gardin G, Guido T, Rosso P. Pronzato P, et al. Chemotherapy. 1991;37(6):449-53. doi: 10.1159/000238893. Chemotherapy. 1991. PMID: 1760945 Clinical Trial.

5

Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.

Pronzato P, Brema F, Amoroso D, Bertelli G, Conte PF, Martini MC, Pastorino G, Rosso R. Pronzato P, et al. Breast Cancer Res Treat. 1990 Nov;17(1):51-4. doi: 10.1007/BF01812684. Breast Cancer Res Treat. 1990. PMID: 2095927 Clinical Trial.

6

Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.

Pronzato P, Amoroso D, Bertelli G, Queirolo P, Sertoli MR, Rosso R. Pronzato P, et al. Anticancer Res. 1990 Nov-Dec;10(6):1743-5. Anticancer Res. 1990. PMID: 2126683

7

The role of surgery in the combined treatment of locally advanced breast cancer.

Canavese G, Catturich A, Battistini G, Caroti C, Pronzato P, Gardin G, Amoroso D, Bertelli G, Conte PF, Tomao S, et al. Canavese G, et al. Among authors: pronzato p. Oncology. 1989;46(6):353-6. doi: 10.1159/000226749. Oncology. 1989. PMID: 2587002 Clinical Trial.

8

Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.

Pronzato P, Campora E, Amoroso D, Bertelli G, Botto F, Conte PF, Sertoli MR, Rosso R. Pronzato P, et al. Am J Clin Oncol. 1989 Dec;12(6):481-5. doi: 10.1097/00000421-198912000-00004. Am J Clin Oncol. 1989. PMID: 2589228

9

Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.

Rosso R, Boccardo F, Brema F, Sertoli MR, Amoroso D, Bertelli G, Pronzato P. Rosso R, et al. Among authors: pronzato p. Anticancer Res. 1989 Jul-Aug;9(4):1153-6. Anticancer Res. 1989. PMID: 2817796

10

Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer.

Pronzato P, Amoroso D, Ardizzoni A, Bertelli G, Canobbio L, Conte PF, Cusimano MP, Fusco V, Gulisano M, Lionetto R, et al. Pronzato P, et al. Am J Clin Oncol. 1987 Oct;10(5):404-6. doi: 10.1097/00000421-198710000-00007. Am J Clin Oncol. 1987. PMID: 3310605 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters